Biological properties and characterization of several variations of a clinical human plasma-based skin substitute model and its manufacturing process.
biomaterial
dermal matrix
fibrin
human plasma
scaffold
tissue-engineered skin substitute
Journal
Regenerative biomaterials
ISSN: 2056-3418
Titre abrégé: Regen Biomater
Pays: England
ID NLM: 101652150
Informations de publication
Date de publication:
2024
2024
Historique:
received:
22
05
2024
revised:
07
08
2024
accepted:
11
09
2024
medline:
29
10
2024
pubmed:
29
10
2024
entrez:
29
10
2024
Statut:
epublish
Résumé
Human plasma is a natural biomaterial that due to their protein composition is widely used for the development of clinical products, especially in the field of dermatology. In this context, this biomaterial has been used as a scaffold alone or combined with others for the development of cellular human plasma-based skin substitutes (HPSSs). Herein, the biological properties (cell viability, cell metabolic activity, protein secretion profile and histology) of several variations of a clinical HPSS model, regarding the biomaterial composition (alone or combined with six secondary biomaterials - serine, fibronectin, collagen, two types of laminins and hyaluronic acid), the cellular structure (trilayer, bilayer, monolayer and control without cells) and their skin tissue of origin (abdominal or foreskin cells) and the manufacturing process [effect of partial dehydration process in cell viability and comparison between submerged (SUB) and air/liquid interface (ALI) methodologies] have been evaluated and compared. Results reveal that the use of human plasma as a main biomaterial determines the
Identifiants
pubmed: 39469583
doi: 10.1093/rb/rbae115
pii: rbae115
pmc: PMC11513639
doi:
Types de publication
Journal Article
Langues
eng
Pagination
rbae115Informations de copyright
© The Author(s) 2024. Published by Oxford University Press.